Launches National IVD validation portal and protocols; highlights India’s strengthening health research ecosystem
AHLL will become a 100% subsidiary of AHEL with 99.42% held by AHEL and balance in the ESOP pool
NouvNeu001 is the world’s first allogeneic iPSC-derived cell therapy for Parkinson’s disease to receive this designation
Program provides access to Lilly-trained artificial intelligence to help accelerate breakthrough medicines
CGX-926 is the first clinical candidate addressing MC4R-deficient genetic obesity
Combination creates a leading, next generation claims operating system for payers, with end-to-end AI capabilities for claims, payments, care & utilization management, payment integrity, and member engagement, serving 115+ health plans
Bain Capital and Cinven will each retain a minority stake, reflecting their ongoing confidence in STADA’s future growth
He has successfully led the development of 15 approved drugs worldwide across various therapeutic areas over his more than 20-year career
AiMeD noted that proposed GST changes—to either 5% or 18%—both present significant risks requiring carefully nuanced consideration
The first pillar is advanced manufacturing, focused on upgrading existing CDMO
Subscribe To Our Newsletter & Stay Updated
